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The balance between proliferation and transcription of angiogenic factors of
mesenchymal stem cells in hypoxia
Arina T. Buizera,b, Sjoerd K. Bulstraa, Albert G. Veldhuizena and Roel Kuijerb
aDepartment of Orthopedic Surgery, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands;
bDepartment of Biomedical Engineering, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
ABSTRACT
Bridging large bone defects with mesenchymal stromal cells-seeded scaffolds remains a big
challenge in orthopedic surgery, due to the lack of vascularization. Within such a cell–scaffold
construct, cells are exposed to ischemic conditions. When human mesenchymal stem cells
(hMSCs) encounter hypoxic conditions, they show higher cell proliferation than at ambient
oxygen levels. However, when hMSCs are exposed to prolonged ischemia, cell proliferation ceases
completely. Exposure of hMSCs to hypoxic conditions is known to result in the transcription of
angiogenic factors (AGF), which can promote the development of new blood vessels. In this study,
we investigated at which oxygen level hMSC proliferation and the transcription of AGF were
optimal. Human bone marrow-derived hMSCs were cultured at 0.1, 1, 2, 3, 4, 5, and 21% oxygen.
Cell proliferation over 14 days was assayed using a DNA quantification method. hMSC metabolic
activity over 14 days was measured using a MTT test. Quantitative RT-PCR was used to assess
mRNA levels of angiogenic factors at the tested oxygen percentages. hMSCs showed the highest
cell proliferation rate at 1% oxygen. The highest corrected cell metabolic rate was found at 21%
oxygen, followed by 2% oxygen. HIF1α transcription did not increase under hypoxic conditions
compared to 21% oxygen conditions. However, transcription of VEGF and ANG-1 was significantly
higher at 2% oxygen than at 21% O2. The optimum oxygen range at which hMSCs proliferated
rapidly and angiogenic factors ANG-1 and VEGF simultaneously came to expression was from 1 to
2% oxygen.
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One of the biggest challenges in the regeneration of
bone is the establishment of a vascular network in
large cell-seeded scaffolds. Due to the lack of a vascular
network at implantation, cells in the center of a large
scaffold are deprived of sufficient oxygen (1,2). In par-
ticular, in poorly vascularized tissue, as is the case with
bone, sufficient vascular ingrowth is hard to achieve.
Moreover, the scaffold is implanted in a bone defect site
that usually already has impaired vascularization due to
disruption of bone and periost integrity. These two
conditions expose the cells seeded on a scaffold to an
unfavorable, anoxic environment immediately after
implantation in bone.
For transport over distances larger than several
millimeters within the body, oxygen is mainly bound
to hemoglobin. When bound to hemoglobin in erythro-
cytes, oxygen is transported rapidly and efficiently over
large distances to vascularized tissues. After having
been released from hemoglobin, oxygen is transported
to the cells through diffusion. Diffusion is a relatively
slow process, and oxygen can travel only short dis-
tances (3). The maximum diffusion distance of oxygen
within the body is 100–200 µm (4). The presence of a
vascular network in a cell–scaffold complex is therefore
essential for sufficient oxygen provision to the cells.
Several methods to improve vascular supply within
tissue-engineered scaffolds have been studied, such as
application of vascular growth factors on scaffolds to
stimulate vascular ingrowth after implantation, design
of scaffolds with micro channels that mimic blood
vessel structures, and preculturing of cell-seeded scaf-
folds in bioreactors, so that growth of a vascular net-
work can be initiated prior to implantation of a scaffold
(1,5). Still, many techniques aiming at improvement in
vascularization within large, artificial cells–scaffold
complexes, require vascular ingrowth after implanta-
tion of the scaffold.
Vascular ingrowth is stimulated by angiogenic fac-
tors (AGFs). These are proteins that promote the
sprouting of new blood vessels from the already exist-
ing vascular network in the near surroundings. AGFs
CONTACT Arina T. Buizer a.t.buizer@umcg.nl University of Groningen, University Medical Center Groningen, Department of Orthopedic Surgery
(BB51), Postbus 30001, 9700 RB Groningen, The Netherlands.
CONNECTIVE TISSUE RESEARCH
http://dx.doi.org/10.1080/03008207.2017.1289189
© 2017 Arina T. Buizer, Sjoerd K. Bulstra, Albert G. Veldhuizen, and Roel Kuijer. Published with license by Taylor & Francis.
This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/),
which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
are produced endogenously in response to among
others, hypoxia, low pH, hypoglycemia, and an inflam-
matory reaction (4). The central factor that regulates
the production of AGFs in response to hypoxia is
hypoxia induced factor 1α (HIF-1α) (Figure 1). HIF-
1α is transcribed, produced, and metabolized continu-
ously in all human cells, but HIF-1α degradation is
slowed down under hypoxic conditions. This “angio-
genic cascade” starts with the coupling of HIF-1α to
HIF-1β in the nuclei of human cells (6). The HIF
complex binds to the hypoxia-responsive element
(HRE) in the promoters of the genes of the AGFs,
initiating transcription (6). Subsequently, several
AGFs will be synthesized that stimulate several phases
of vascular growth, such as increasing vascular perme-
ability (VEGF, FGF), migration and proliferation of
endothelial cells (VEGF-R2), and maturation of blood
vessels (TGF-β1, ANG-1, and PDGF-β) (7). Whenever
oxygen supply is restored, HIF-1α will be metabolized
again; therefore, the angiogenic cascade can no longer
be initiated, and cells will cease the transcription of
AGF genes. Whenever oxygen supply is demolished,
cell metabolism decreases and cell death occurs (8).
Obviously, the transcription of AGF will be lowered
and eventually stop as well. We therefore hypothesize
that AGF expression plotted against oxygen level results
in a bell-shaped curve; at very low oxygen conditions,
AGF expression is absent or very low, and at low
oxygen conditions, AGF expression rises and in suffi-
cient oxygen conditions AGF expression descends
again. It is not yet known at which oxygen levels exactly
AGF expression increases and decreases.
Human mesenchymal “stem” cells (hMSCs) show
great potential as the cell component for bone regen-
eration. These cells can easily be isolated from various
types of tissue, differentiate into several cell types and
have trophic effects (9,10). A frequently used source of
hMSCs is bone marrow. Naturally, bone marrow-
derived hMSCs (BM-hMSCs) reside in the niche areas
of bone marrow, where the standard partial oxygen
level is 1–2% (11,12), which equals 1.0–7.1 kPa or
7.5–53.2 mmHg oxygen. However, in cell culture stu-
dies, BM-hMSCs are often cultured at ambient oxygen
level (21%), which is a hyperoxic situation for the cells.
For standardization purposes, any oxygen percentage
below 21% will be referred to as hypoxia in this study
and 21% as normoxia. Results of previous studies show
that BM-hMSCs tend to proliferate faster at hypoxic
oxygen levels than at 21% oxygen (13–16). At very low
oxygen conditions of 1% O2 and lower, a decreased
proliferation rate has been reported (17,18). In conclu-
sion, the curve of BM-hMSC proliferation plotted
against oxygen level seems to have a bell-shaped curve
too; at very low oxygen levels, cell proliferation is low,
until cell death occurs at severe hypoxia (8), while a
slight increase in oxygen tension until a certain level
results in higher cell proliferation. It is not yet known at
which oxygen levels exactly BM-hMSC proliferation
increases and decreases. For hMSCs derived from tissue
types other than bone marrow, the oxygen levels at
which cell proliferation increases and decreases may
be different.
We hypothesize that if an overlay of the AGF expres-
sion curve and the cell proliferation curve were created,
there would be a window in oxygen level at which BM-
hMSCs cultured under hypoxia show increased AGF
expression and still proliferate. If BM-hMSCs are cul-
tured at oxygen levels within this window, optimal
proliferation and AGF expression may be accom-
plished, and this window may serve as a basis for
further clinical research. This study therefore aims at
finding the oxygen concentration range at which
hMSCs both proliferate and induce vascular ingrowth
through expression of AGF.
Figure 1. Schematic representation of the initiation of the angiogenic cascade in a cell. Whenever sufficient oxygen is supplied to
the cell (upper half of figure), HIF-1α is metabolized in the cytoplasm, and the angiogenic cascade is not started. Whenever
insufficient oxygen is supplied to the cell (lower half of the picture), HIF-1α proceeds to the cell nucleus and binds to HIF-1β. The
HIF-1α-HIF-1β-complex binds to the HRE, and angiogenic factor transcription is initiated.
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Materials and methods
Isolation and culture of MSCs
Reaming debris from the femur acquired during total
hip replacement surgeries was used as a source of bone
marrow. All three donors were females, aged 55, 71 and
85. The ethics committee of University Medical Center
Groningen approved the study protocol.
From each patient, 12 ml of bone marrow was aspirated
using a Jamshidi bone marrow aspiration needle (Beckton
Dickinson, Franklin Lakes, NJ) and divided into four equal
portions. The bone marrow portions were diluted with
phosphate-buffered saline (PBS), and subsequently,
density gradient centrifugation (Histopaque 1077, Sigma-
Aldrich, Steinheim, Germany) was done according to the
manufacturer’s instructions. Themononuclear cell fraction
was seeded in T75 tissue culture flasks (Greiner Bio-one,
Alphen aan den Rijn, the Netherlands). A standard med-
ium, consisting of minimal essential medium-alpha
(α-MEM, Invitrogen, Paisley, UK) supplemented with
10% heat-inactivated fetal bovine serum (FBS,
Invitrogen), 0.1 mM Ascorbic Acid-2-Phosphate (AA2P,
Fluka, Steinheim, Germany) and 2% antibiotic–antimyco-
tic (Invitrogen) was added, and the cells were cultured in a
humidified atmosphere with 5% CO2 at 37 °C. The med-
ium was changed twice weekly. When 70% confluence was
reached, the obtained cells were suspended in a full culture
medium containing 7.5% DMSO (Sigma-Aldrich), frozen,
and stored in liquid nitrogen. For each oxygen percentage
tested, a new batch of cells was thawed and grown up to
70% confluence prior to the experiment.
Characterization of MSCs
For characterization, hMSCs were thawed and cultured
in T75 tissue culture flasks with standard medium in a
humidified atmosphere with 5% CO2 at 37 °C until
passage 3. hMSCs from each individual donor were
tested in triplicate.
To assess the antigen expression profile of the iso-
lated cells, a standard set of antibodies was conjugated
to the cells (BD Stemflow Human MSC Analysis Kit,
BD Biosciences, San Diego, CA) according to the man-
ufacturer’s instructions. Fluorescent cells were counted
using a FACS machine (FACSCalibur, Beckton
Dickinson, Franklin Lakes, NJ). The Kaluza software
package (Beckman Coulter, Brea, CA) was used to
analyze the FACS data.
The cells isolated from bone marrow were differen-
tiated into osteogenic, adipogenic, and chondrogenic
lineages. To assess osteogenic potential, 3750 cells/cm2
were cultured in a 24-well tissue culture plate (Greiner
Bio-one) with osteogenic medium [α-MEM, 2%
antibiotic–antimycotic, 10% heat-inactivated FBS, 100
nM dexamethasone (Sigma-Aldrich), 0.05 mM β-gly-
cerophosphate (Sigma-Aldrich) and 50 µM AA2P] for
two weeks. Thereafter, alkaline phosphatase production
in the cells was assayed using an alkaline phosphatase
assay (Leukocyte alkaline phosphatase kit; Sigma)
according to the manufacturer’s instructions. To assess
adipogenic potential, 5 000 cells/cm2 were cultured in a
24-well tissue culture plate with adipogenic medium [α-
MEM, 2% antibiotic–antimycotic, 10% heat inactivated
FBS, 1 µM dexamethasone, 0.5 mM IBMX (Sigma-
Aldrich), 60 µM indomethacin (Sigma-Aldrich), and
10 µM human insulin (Invitrogen)] for three weeks.
After three weeks, the cells were fixated using 3.7%
paraformaldehyde (Boom, Meppel, the Netherlands).
Subsequently, the cells were stained using a 0.3% (w/
v) Oil Red O (Sigma-Aldrich) in 99% 2-propanol solu-
tion, diluted 1.67 times in water.
To assess chondrogenic potential, 250,000 cells were
seeded in 15-ml conical tubes and spun down in a cen-
trifuge. The cell pellet thus created was cultured with
chondrogenic medium [α-MEM, 2% antibiotic–antimy-
cotic, 0.1 mM AA2P, 0.1 µM dexamethasone, 1% ITS+
(Invitrogen), 40 µg/ml L-proline (Sigma-Aldrich) and 10
ng/ml TGF-β1 (R&D Systems, Minneapolis, MN)] for
two weeks. Next, the cell pellets were fixed with parafor-
maldehyde (3.7%), dehydrated in a series of increasing
concentration ethanol solutions, and embedded in paraf-
fin. Fivemicrometer sections were stained using 1% alcian
blue (Boom) in 0.1 M HCl solution and counterstained
with 0.2% (w/v) nuclear fast red (Merck, Darmstadt,
Germany) staining solution.
Cell proliferation
hMSCs from each individual donor were seeded eight-
fold in a 96-wells plate (Greiner Bio-one), at passage 3
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and at a density of 3,125 cells/cm2. The cells were
cultured with 100 µl/well standard medium without
antibiotic–antimycotic in a hypoxic cabinet (Invivo200,
Ruskinn, Glamorgan, UK) at gas mixtures containing
5% CO2 and 0.1, 1, 2, 3, 4, or 5% O2, at 37 °C and 100%
humidity. As a control, cells cultured at 21% O2, 5%
CO2, and at 37 °C were used. After 1, 3, 7, 10, and 14
days of incubation, the cell layers were briefly rinsed
with PBS once and frozen at -80 °C. At the end of the
experiment, the cells were thawed, and the amount of
DNA per well was quantified using the CyQUANT®
Cell Proliferation Assay Kit (Invitrogen) according to
the manufacturer’s instructions. A DNA standard curve
was made using lambda DNA, according to the manu-
facturer’s instructions.
Cell metabolic rate
Cell metabolic rate was assessed using a (3-(4,5-
Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide/
thiazolyl blue tetrazolium bromide (MTT) assay. In a 24-
wells plate, hMSCs from each individual donor were
seeded at a density of 5,000 cells/cm2 in triplicate and
incubated with 1 ml standard medium without antibio-
tic–antimycotic per well at 0.1, 1, 2, 3, 4, or 5% O2 in a
hypoxic cabinet. Cells were used for the experiments at
passage 3. After 1, 3, 7, 10, and 14 days of incubation, the
cells were washed with PBS once and full cell culture
medium supplemented with 0.5 mg/ml of thiazolyl blue
tetrazolium bromide (Sigma Aldrich) was added. The cells
were incubated with the MTTmedium for 2.5 hours in the
hypoxic cabinet. After incubation, cells were carefully
washed with PBS once, and 500 µl of 2-propanol (Merck)
was added to each well. The plates were placed on a shaker
for two minutes, and the 2-propanol supernatants were
subsequently pipetted intomicrocentrifuge vials and stored
at 4 °C. When a time range at a specific O2 percentage was
completed, the supernatants were centrifuged for 30 sec-
onds at maximum speed. The supernatants (100 µl) were
pipetted in a 96-well plate in triplicate, and the absorbance
was read at 570 nm using a plate reader (Fluostar Optima,
BMG labtech, Olfenburg, Germany).
The cell metabolic rate was corrected for the number
of cells per condition and per time point using
Equation (1):
Corrected Cell Metabolic Rate ðCCMRÞ ¼
Average MTT value
ðper time point and per oxygen percentageÞ
Average number of cells per well
ðper time point and per oxygen percentageÞ
(1)
Angiogenic factor expression
For RNA isolation, hMSCs from each individual donor
were seeded at a density of 11,000 cells/cm2 in 6-well
plates (Greiner Bio-one) and cultured with 3 ml of stan-
dard medium without antibiotic–antimycotic at 21% O2
for two days. Cells were seeded at passage 3. The experi-
ments were performed in triplicate. After two days of
culture, the cells were placed in a hypoxic cabinet and
maintained at gas mixtures containing 5% CO2 and 0.1, 1,
2, 3, 4, or 5% O2, at 37 °C and 100% humidity for six
hours. Subsequently, the cells were lysed using RLT buffer
(RNeasy Micro Kit, Qiagen, Hilden, Germany), and the
lysates were stored at -80 °C until RNA was isolated. RNA
was isolated using a RNeasy Micro Kit according to the
manufacturer’s instructions. As a control, cells cultured at
21% O2 and 5% CO2 and at 37 °C were used. The amount
of isolated RNA was measured using spectrophotometry
(NanoDrop 1000, NanoDrop, Wilmington, DE). Copy
DNA (cDNA) was made out of 200 ng RNA using a
DNA polymerase protocol (iScript cDNA Synthesis Kit,
BioRad, Hercules, CA) according to the manufacturer’s
instructions. The 10-times diluted cDNA was stored at
-80 °C. qPCR was done using the iQ™ SYBR® Green
Supermix kit (BioRad, Hercules, CA) according to the
manufacturer’s instructions on a PCR machine (CFX384
Real Time System, BioRad). hRPL13a and B2M were used
as reference genes. Several AGFs were assayed; primer
sequences are given in Table 1. For calculation of expres-
sion levels of all genes, the Livak method was used (19).
Statistical analysis
SPSS 20.0 was used for all statistical analyses. Data were
tested for normality, which could not be confirmed in all
tests. As outcomes of more than two oxygen percentages
were compared, Kruskal–Wallis tests were used for data
analysis. A p value of 0.05 or lower was considered to be
significant. A p value of > 0.05 and < 0.10 was considered a
trend.
Results
Human mesenchymal stem cells
The cell populations obtained from the three donors met
the criteria as stated by the International Society of
Cellular Therapy (ISCT) (20). The cells were selected
from the nucleated cell fraction of the bone marrow
samples by their ability to adhere to tissue culture plastic.
The antigen expression profile as assayed using FACS
met the ISCT criteria. No differences in antigen
expression profile between donors could be found. The
differentiation potential in adipogenic, chondrogenic,
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and osteogenic cell lineages was confirmed through
comparison with previous literature (21).
Cell proliferation
hMSC proliferation was comparable at most oxygen per-
centages, except when cells were cultured at 1% O2
(Figure 2). Already on the first day after cell seeding, cell
proliferation was significantly higher in cells cultured at 1%
O2 than at most other oxygen percentages (p values shown
in Table 2). The lowest oxygen percentage that was tested,
0.1%, resulted in significantly lower cell proliferation than
most other oxygen percentages from day 7 onwards. Cells
cultured at 21% O2 rapidly proliferated in the first three
days after seeding. On day 4, cell proliferation at 21% O2
decreased. At day 14, the cell proliferation was significantly
lower at 21% oxygen than at 1, 2, 3, and 4% O2.
Cell metabolic activity
The corrected cell metabolic rate (CCMR) was significantly
higher in cells cultured at 21% O2 than in cells cultured at
most other oxygen percentages after day 3 (see Figure 3,
p values are shown in Table 3). When comparing the
CCMR at 21% and 0.1% oxygen, there was a trend toward
a significant difference. The second highest CCMR was
found in cells cultured at 2% oxygen, but the CCMRs
were similar at all oxygen percentages other than 21% O2.
Angiogenic factor expression
Both B2M and RPL13a were used as reference primers to
calculate the normalized fold expression of several AGF.
Gene expression was calculated using each reference
primer and both gave similar results. Only the normalized
fold expression as referred to RPL13a expression is shown
here. The reference condition used was gene expression at
21% oxygen (set at 1 in Figure 4). The expression of
vascular endothelial growth factor (VEGF) was highest
Figure 3. Line graph representing the corrected cell metabolic
rate. This was calculated at five time points over 14 days for
several oxygen percentages. Error bars represent the standard
error of the mean.
Table 3. P values of differences in CCMR of 21% oxygen as
compared to all other tested oxygen percentages, for five time
points.
Time (days)
O2 percentage (%) Compared to (%) 1 3 7 10 14
21 0.1 0.55 0.08 0.08 0.08 0.08
21 1 0.83 0.05* 0.05* 0.05* 0.05*
21 2 0.83 0.64 0.05* 0.05* 0.05*
21 3 0.27 0.05* 0.05* 0.05* 0.05*
21 4 0.51 0.10 0.05* 0.05* 0.05*
21 5 0.83 0.05* 0.05* 0.05* 0.05*
1 2 0.66 0.13 0.05* 0.05* 0.05*
p values ≤ 0.05 are indicated with an asterisk.
Figure 2. Line graph representing the number of cells per well
at several oxygen percentages measured at five time points
over 14 days. Error bars represent the standard error of the
mean.
Table 2. Table indicating p values of differences in cell prolifera-
tion of 0.1, 1, and 21% oxygen as compared to all other tested
oxygen percentages, for five time points.
Time (days)
O2 percentage (%) Compared to (%) 1 3 7 10 14
0.1 1 0.00* 0.06 0.00* 0.00* 0.00*
0.1 2 0.13 0.88 0.00* 0.00* 0.00*
0.1 3 0.18 0.01* 0.00* 0.00* 0.00*
0.1 4 0.16 0.88 0.00* 0.00* 0.00*
0.1 5 0.18 0.41 0.02* 0.08 0.00*
0.1 21 0.21 0.08 0.00* 0.00* 0.00*
1 2 0.00* 0.00* 0.00* 0.00* 0.00*
1 3 0.00* 0.00* 0.00* 0.00* 0.00*
1 4 0.00* 0.00* 0.00* 0.00* 0.00*
1 5 0.00* 0.00* 0.00* 0.00* 0.00*
1 21 0.54 0.58 0.00* 0.00* 0.00*
21 2 0.02* 0.00* 0.01* 0.00* 0.00*
21 3 0.00* 0.00* 0.01* 0.21 0.00*
21 4 0.09 0.00* 0.65 0.00* 0.03*
21 5 0.01* 0.00* 0.00* 0.34 0.15
Significant p values are indicated with an asterisk.
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in the 1%–3% oxygen range, (p < 0.05), especially at 2%
oxygen (See Figure 4). Angiopoetin-1 (ANG-1) had a
similar expression profile, but expression was only sig-
nificantly higher at 2%O2. There was a significantly lower
expression of transforming growth factor-β1 (TGF-β1)
and HIF-1α in hMSCs exposed to hypoxic conditions,
yet the highest expression of these factors was still found
in cells cultured at 2% O2. The expression of fibroblast
growth factor-2 (FGF-2) remained fairly constant under
hypoxic conditions. Expression levels of VEGF-receptor2
(VEGF-R2) and platelet-derived growth factor-β (PDGF-
β) were very low to nihil in hMSCs (data not shown).
Discussion
The first aim of this study was to find the oxygen
concentration range at which hMSCs proliferate the
most. The second aim was to investigate the expression
of AGF by hMSCs in response to decreasing oxygen
concentrations.
Human MSC showed the highest proliferation rate
when cultured at 1% oxygen. When the cell metabolic
rate was corrected for the number of cells, cells cultured
at 21% oxygen showed the highest CCMR. The expres-
sion of VEGF and ANG-1 in hMSCs was highest at 2%
oxygen. Other AGF were underexpressed compared to
the AGF expression in hMSCs cultured at 21% oxygen.
Bone marrow-derived stem cells reside in a niche
where 1–2% oxygen is available (11,12); this being their
natural habitat, it was expected that the highest cell
proliferation rates would be found at 1%–2% oxygen.
As the oxygen percentage increased, cell proliferation
happened at a slower pace. hMSCs do not naturally
reside under such high oxygen percentages, and there-
fore, proliferation may be impaired. Previous research-
ers found similar results (12,22–24). However, exposing
the cells to an even lower oxygen percentage of 0.1%
resulted in lower cell proliferation. Potier et al. (18)
found that prolonged severe hypoxia resulted in lower
cell survival than when cells were exposed to hypoxia
for only a short period of time, which corroborates with
our findings.
The highest corrected cell metabolic rate was found
at 21% O2. The cell metabolic activity was assayed
using an MTT test, which measures the mitochondrial
activity within a cell. Oxidative phosphorylation,
which is the process of aerobic production of ATP,
takes place in the cell mitochondria. We hypothesize
that the high amount of oxygen to which cells are
exposed, at 21% oxygen, leads to higher oxidative
phosphorylation and thus to higher mitochondrial
activity in the cells. This hypothesis is supported by
the findings of Duguez et al. (25), who exposed myo-
cytes to normoxic and hypoxic conditions. They found
that cell mitochondrial activity was higher in cells
exposed to normoxia than in cells exposed to hypoxia.
Secondly, Grayson et al. (16) and Lavrentieva et al.
(26) found that under hypoxic conditions, glucose
consumption and lactate production were higher in
cells cultured under low oxygen conditions than in
cells cultured at 21% oxygen, which indirectly indi-
cates the switch from aerobic to anaerobic metabo-
lism. The mitochondria are thus less activated under
hypoxic conditions. The lower mitochondrial activity
in cells cultured under hypoxic conditions might
result in lower MTT values than those found in cells
cultured under normoxic conditions. On the other
hand, Weir et al. (27) found that mitochondrial activ-
ity of keratinocytes assessed using the MTT assay was
not sensitive to oxygen concentration. Apparently,
sensitivity to oxygen levels is cell type dependent.
The angiogenic cascade is initiated by stabilization of
HIF-1α (6,28–30). Our results support this theory, as
expression of HIF-1α neither increased nor decreased
under hypoxic conditions. Previous studies corroborate
with these results (31), and increased HIF-1α protein
levels have been found in cells cultured under hypoxic
conditions (15). Some authors nonetheless state that
HIF-1α expression is upregulated under hypoxic con-
ditions, as their results with cultured MSCs show (17).
In Holzwarth’s study, glyceraldehyde-phosphate dehy-
drogenase (GAPDH) was used as a reference gene, and
since GAPDH is active in oxidative phosphorylation, its
expression may be effected when cells switch from
Figure 4. Bar chart representing the normalized fold expression
of ANG-1, TGF-β, FGF-2, VEGF, and HIF-1α at several oxygen
percentages when compared to expression of these factors at
21% oxygen. Normalized fold expressions that differ signifi-
cantly from normalized fold expression at 21% oxygen are
indicated with an asterisk. Error bars represent the standard
error of the mean.
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aerobic to anaerobic conditions. RPL13a is considered
as the reference gene of choice for cells cultured under
hypoxic conditions (32).
One of the major angiogenic factors that comes to
expression in response to activation of the HRE by
binding with the HIF-1α complex is VEGF. The
increase in VEGF mRNA quantities after exposure of
hMSCs to hypoxic conditions has been described by
many other researchers (18,33–35). The other angio-
genic factor we found to be overexpressed under
hypoxic conditions was ANG-1. The expression of
ANG-1 in hMSCs cultured under hypoxic conditions
has been studied less frequently, but Hu et al (36).
found increased HIF-1α, VEGF, and ANG-1 protein
levels in mouse MSCs, which corroborates our results.
In our study, FGF-2 and TGF-β1 generally came to
expression less under hypoxic conditions than under
normoxic conditions. The AGF primer set was com-
posed aiming at representation of AGF active during all
stages of vascular development—initiation of vascular
growth, migration, and proliferation of blood vessel
cells, and finally maturation of the newly formed
blood vessel. Initiation of blood vessel formation is
importantly regulated by VEGF (37,38). Perhaps vascu-
lar ingrowth is mainly initiated by MSCs and is the
process preceded by release of AGF by other cells
involved in vascular sprouting (37,38). Release of
FGF-2 and TGF-β1 by hMSCs would thus not be
necessary, which may explain why FGF-2 and TGF-
β1 expressions in hMSCs did not increase.
The occurrence of a peak AGF expression in hMSCs
cultured at 2% O2 may seem remarkable, as this oxygen
percentage is the same as in their natural habitat. The
implication is that they naturally and continuously
produce AGF, but it is not clear yet whether this is
the case. This AGF production can be of great value in
fracture hematomas, where oxygen tension is very low,
around 1% (39). After a fracture, repair cells such as
MSCs are attracted toward the fracture hematoma
through the release of chemokines, initiating the
growth of fresh, vascularized bone tissue (40–42). The
presence of AGF-releasing hMSCs in a fracture hema-
toma at this oxygen percentage may thus support the
attraction of cells that form a new vascular supply.
The hMSCs used in this study were isolated under
normoxic conditions. It could therefore be that a spe-
cific population was selected that is more adapted to
living under normoxic conditions than cells which have
only been exposed to hypoxic conditions. An effort was
made to isolate hMSCs from full bone marrow under
hypoxic conditions, but the isolated cells did not reach
70% confluence, even after four weeks of culturing
(data not shown). Other authors also report difficulties
isolating hMSCs from full bone marrow under hypoxic
conditions (17). This is why cells isolated under nor-
moxic conditions were used in the experiments.
However, the cells used in our study performed well
in terms of cell proliferation, metabolic activity, and
AGF production under hypoxic conditions, so the nor-
moxic conditions during isolation do not seem to have
influenced the outcomes of culture experiments under
hypoxia in a negative way.
As there is variation in hMSC characteristics
between different donors, we did not want to add
gender as another factor that could influence stem cell
characteristics. It was therefore chosen to use bone
marrow only from female donors and not from both
sexes. The results may be different if the same experi-
ments are performed on hMSCs derived from male
donors.
These results indicate that exposing hMSCs to an
oxygen level of 1–2% results in the highest cell prolif-
eration and the highest expression of VEGF and ANG-
1. This may indicate that at 1%–2% oxygen hMSCs
stimulate vascular ingrowth the most, while cell expan-
sion takes place at the highest rate. This optimal oxygen
range should be taken into account in future research
when aiming at the most effective tissue regeneration.
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